RGS22 anticorps (AA 201-504) (HRP)
Aperçu rapide pour RGS22 anticorps (AA 201-504) (HRP) (ABIN7167609)
Antigène
Voir toutes RGS22 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 201-504
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Regulator of G-protein signaling 22 protein (201-504AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- RGS22 (Regulator of G-Protein Signaling 22 (RGS22))
-
Autre désignation
- RGS22
-
Sujet
-
Background: Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form.
Aliases: FLJ40080 antibody, FLJ75004 antibody, MGC102908 antibody, PRTD-NY2 antibody, Regulator of G-protein signaling 22 antibody, RGS22 antibody, RGS22_HUMAN antibody
-
UniProt
- Q8NE09
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling
Antigène
-